Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS Registry

Background The ambulance system is vital for the early management of patients with ST‐segment–elevation myocardial infarction, reducing delays in diagnosis and treatment. This study examined the impact of transport mode on reperfusion therapy and mortality among patients with ST‐segment–elevation my...

Full description

Saved in:
Bibliographic Details
Main Authors: Aviad Rotholz, Tsahi T. Lerman, Jenan Awesat, Alon Eisen, Roy Beigel, Elias Kanani, Omri Braver, Katia Orvin
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.040813
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849245448206811136
author Aviad Rotholz
Tsahi T. Lerman
Jenan Awesat
Alon Eisen
Roy Beigel
Elias Kanani
Omri Braver
Katia Orvin
author_facet Aviad Rotholz
Tsahi T. Lerman
Jenan Awesat
Alon Eisen
Roy Beigel
Elias Kanani
Omri Braver
Katia Orvin
author_sort Aviad Rotholz
collection DOAJ
description Background The ambulance system is vital for the early management of patients with ST‐segment–elevation myocardial infarction, reducing delays in diagnosis and treatment. This study examined the impact of transport mode on reperfusion therapy and mortality among patients with ST‐segment–elevation myocardial infarction from 2000 to 2021. Methods Data from the ACSIS (Acute Coronary Syndrome Israeli Survey) registry 2000 to 2021 were analyzed. Three transport methods of patients with ST‐segment–elevation myocardial infarction were evaluated. The impact on patient outcomes was assessed. Temporal trends from early (2000–2010) and late (2013–2021) periods were compared. Results Of 8035 patients with ST‐segment–elevation myocardial infarction, 52.9% were transported by mobile intensive care units, 13.1% by basic life support ambulances, and 34% self‐transported. Use of mobile intensive care units increased from 48.7% to 60.9% (P<0.001), while self‐transport decreased from 36.8% to 28.7% (P<0.001). Time from hospital arrival to primary percutaneous coronary intervention significantly decreased for mobile intensive care unit patients (60 to 36 minutes; P<0.001) and for basic life support patients (90 to 73 minutes; P=0.002), while self‐transport showed no significant change. Adjusted analysis revealed a decrease in 30‐day major adverse cardiovascular events (odds ratio, 0.53; P<0.001) and 1‐year mortality rates (hazard ratio, 0.84; P<0.05) for the entire cohort with no difference within or upon comparing transport methods between periods. Primary percutaneous coronary intervention rates and guideline‐directed medical therapy also rose significantly (P<0.001). Conclusions Improved major adverse cardiovascular event and mortality rates are attributed to enhanced in‐hospital and postdischarge care, including primary percutaneous coronary intervention and guideline‐directed medical therapy rather than transport improvements, although these contribute to more stable arrival conditions.
format Article
id doaj-art-488d8d4ff52f43bf88efde9c7982bece
institution Kabale University
issn 2047-9980
language English
publishDate 2025-07-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-488d8d4ff52f43bf88efde9c7982bece2025-08-20T03:58:49ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802025-07-01141310.1161/JAHA.124.040813Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS RegistryAviad Rotholz0Tsahi T. Lerman1Jenan Awesat2Alon Eisen3Roy Beigel4Elias Kanani5Omri Braver6Katia Orvin7Rabin Medical Center Cardiology Division Beilinson and Hasharon Petah Tikva IsraelRabin Medical Center Cardiology Division Beilinson and Hasharon Petah Tikva IsraelRabin Medical Center Cardiology Division Beilinson and Hasharon Petah Tikva IsraelRabin Medical Center Cardiology Division Beilinson and Hasharon Petah Tikva IsraelFaculty of Medical and Health Sciences Tel Aviv University Tel Aviv IsraelGalilee Medical Center Nahariya IsraelSoroka University Medical Center, Ben‐Gurion University Beer‐Sheva IsraelRabin Medical Center Cardiology Division Beilinson and Hasharon Petah Tikva IsraelBackground The ambulance system is vital for the early management of patients with ST‐segment–elevation myocardial infarction, reducing delays in diagnosis and treatment. This study examined the impact of transport mode on reperfusion therapy and mortality among patients with ST‐segment–elevation myocardial infarction from 2000 to 2021. Methods Data from the ACSIS (Acute Coronary Syndrome Israeli Survey) registry 2000 to 2021 were analyzed. Three transport methods of patients with ST‐segment–elevation myocardial infarction were evaluated. The impact on patient outcomes was assessed. Temporal trends from early (2000–2010) and late (2013–2021) periods were compared. Results Of 8035 patients with ST‐segment–elevation myocardial infarction, 52.9% were transported by mobile intensive care units, 13.1% by basic life support ambulances, and 34% self‐transported. Use of mobile intensive care units increased from 48.7% to 60.9% (P<0.001), while self‐transport decreased from 36.8% to 28.7% (P<0.001). Time from hospital arrival to primary percutaneous coronary intervention significantly decreased for mobile intensive care unit patients (60 to 36 minutes; P<0.001) and for basic life support patients (90 to 73 minutes; P=0.002), while self‐transport showed no significant change. Adjusted analysis revealed a decrease in 30‐day major adverse cardiovascular events (odds ratio, 0.53; P<0.001) and 1‐year mortality rates (hazard ratio, 0.84; P<0.05) for the entire cohort with no difference within or upon comparing transport methods between periods. Primary percutaneous coronary intervention rates and guideline‐directed medical therapy also rose significantly (P<0.001). Conclusions Improved major adverse cardiovascular event and mortality rates are attributed to enhanced in‐hospital and postdischarge care, including primary percutaneous coronary intervention and guideline‐directed medical therapy rather than transport improvements, although these contribute to more stable arrival conditions.https://www.ahajournals.org/doi/10.1161/JAHA.124.040813ambulanceMACEmortalitySTEMItransport
spellingShingle Aviad Rotholz
Tsahi T. Lerman
Jenan Awesat
Alon Eisen
Roy Beigel
Elias Kanani
Omri Braver
Katia Orvin
Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS Registry
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
ambulance
MACE
mortality
STEMI
transport
title Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS Registry
title_full Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS Registry
title_fullStr Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS Registry
title_full_unstemmed Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS Registry
title_short Impact of Transport Method in Patients With ST‐Segment–Elevation Myocardial Infarction on Patient Outcomes: Real‐World Data From the ACSIS Registry
title_sort impact of transport method in patients with st segment elevation myocardial infarction on patient outcomes real world data from the acsis registry
topic ambulance
MACE
mortality
STEMI
transport
url https://www.ahajournals.org/doi/10.1161/JAHA.124.040813
work_keys_str_mv AT aviadrotholz impactoftransportmethodinpatientswithstsegmentelevationmyocardialinfarctiononpatientoutcomesrealworlddatafromtheacsisregistry
AT tsahitlerman impactoftransportmethodinpatientswithstsegmentelevationmyocardialinfarctiononpatientoutcomesrealworlddatafromtheacsisregistry
AT jenanawesat impactoftransportmethodinpatientswithstsegmentelevationmyocardialinfarctiononpatientoutcomesrealworlddatafromtheacsisregistry
AT aloneisen impactoftransportmethodinpatientswithstsegmentelevationmyocardialinfarctiononpatientoutcomesrealworlddatafromtheacsisregistry
AT roybeigel impactoftransportmethodinpatientswithstsegmentelevationmyocardialinfarctiononpatientoutcomesrealworlddatafromtheacsisregistry
AT eliaskanani impactoftransportmethodinpatientswithstsegmentelevationmyocardialinfarctiononpatientoutcomesrealworlddatafromtheacsisregistry
AT omribraver impactoftransportmethodinpatientswithstsegmentelevationmyocardialinfarctiononpatientoutcomesrealworlddatafromtheacsisregistry
AT katiaorvin impactoftransportmethodinpatientswithstsegmentelevationmyocardialinfarctiononpatientoutcomesrealworlddatafromtheacsisregistry